Black and Asian cancer patients are less likely to survive in the five years after a donor stem cell transplant than their white counterparts, according to a study and largest of its kind.
The study, published in Lancet Haematology, looked at 30,000 patients who had a stem cell transplant between 2009 and 2020 on the NHS, with 19,000 of these being cancer patients.